CardioLogs® provides an innovative software technology enabling any healthcare professional to accurately and reliably screen patients for cardiovascular diseases. Founded in 2014, CardioLogs® leverages cutting-edge machine learning technology and medical expertise to deliver top ECG interpretation services. Our mission is to empower healthcare professionals and bring cardiology expertise closer to patients.Cardiologs is a medical technology company committed to transforming cardiac diagnostics by utilising medical-grade artificial intelligence and cloud technology. From the very early stages, Cardiologs partnered with leading cardiology and emergency medicine experts to develop a cutting-edge solution that empowers clinicians worldwide to deliver expert cardiac care faster and more efficiently.The Cardiologs ECG Analysis Solution is built on an ever-growing and proprietary database of more than 1,450,000 recordings and is supported by a number of clinical publications that demonstrate leading diagnostic performance.
Total Funding: $23 M
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 26 to 50
Founded: 2014
Sep 2020
- Cardiologs Partners with MicroPort CRM to Distribute its AI-Based Cardiac Diagnostics Solution in France
Dec 2019
- Cardiologs Earns Frost & Sullivan's New Product Innovation Award
Software Engineer (Full-stack) Intern
Paris
Site Reliability Engineer (SRE) Intern
Paris
Regulatory Affairs & Quality Intern
Paris
Product Manager
Paris
Product Analyst
Paris
